165 related articles for article (PubMed ID: 31265056)
1. A mathematical model of HIV dynamics treated with a population of gene-edited haematopoietic progenitor cells exhibiting threshold phenomenon.
Ratti V; Nanda S; Eszterhas SK; Howell AL; Wallace DI
Math Med Biol; 2020 May; 37(2):212-242. PubMed ID: 31265056
[TBL] [Abstract][Full Text] [Related]
2. Modelling coupled within host and population dynamics of [Formula: see text] and [Formula: see text] HIV infection.
Manda EC; Chirove F
J Math Biol; 2018 Apr; 76(5):1123-1158. PubMed ID: 28762130
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H
N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667
[TBL] [Abstract][Full Text] [Related]
4. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Gupta RK; Abdul-Jawad S; McCoy LE; Mok HP; Peppa D; Salgado M; Martinez-Picado J; Nijhuis M; Wensing AMJ; Lee H; Grant P; Nastouli E; Lambert J; Pace M; Salasc F; Monit C; Innes AJ; Muir L; Waters L; Frater J; Lever AML; Edwards SG; Gabriel IH; Olavarria E
Nature; 2019 Apr; 568(7751):244-248. PubMed ID: 30836379
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
Xu L; Yang H; Gao Y; Chen Z; Xie L; Liu Y; Liu Y; Wang X; Li H; Lai W; He Y; Yao A; Ma L; Shao Y; Zhang B; Wang C; Chen H; Deng H
Mol Ther; 2017 Aug; 25(8):1782-1789. PubMed ID: 28527722
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
[TBL] [Abstract][Full Text] [Related]
8. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV.
AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317
[No Abstract] [Full Text] [Related]
9. Clinical Applications of Genome Editing to HIV Cure.
Wang CX; Cannon PM
AIDS Patient Care STDS; 2016 Dec; 30(12):539-544. PubMed ID: 27854119
[TBL] [Abstract][Full Text] [Related]
10. Analysis of an HIV infection model incorporating latency age and infection age.
Wang J; Dong X
Math Biosci Eng; 2018 Jun; 15(3):569-594. PubMed ID: 30380321
[TBL] [Abstract][Full Text] [Related]
11. A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.
Savkovic B; Nichols J; Birkett D; Applegate T; Ledger S; Symonds G; Murray JM
PLoS Comput Biol; 2014 Jun; 10(6):e1003681. PubMed ID: 24945407
[TBL] [Abstract][Full Text] [Related]
12. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
13. A delay-differential equation model of HIV infection of CD4(+) T-cells.
Culshaw RV; Ruan S
Math Biosci; 2000 May; 165(1):27-39. PubMed ID: 10804258
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model for HIV dynamics with multiple infections: implications for immune escape.
Deng Q; Guo T; Qiu Z; Chen Y
J Math Biol; 2024 May; 89(1):6. PubMed ID: 38762831
[TBL] [Abstract][Full Text] [Related]
15. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of virus and immune response in multi-epitope network.
Browne CJ; Smith HL
J Math Biol; 2018 Dec; 77(6-7):1833-1870. PubMed ID: 29476197
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
18. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 inhibits haematopoiesis via microRNA secreted by virus-infected CD4+ T cells.
Padmanabhan U; Dahake R; Chowdhary AS; Koka PS
Eur J Haematol; 2020 Mar; 104(3):170-180. PubMed ID: 31733152
[TBL] [Abstract][Full Text] [Related]
20. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
Oswald-Richter K; Grill SM; Leelawong M; Tseng M; Kalams SA; Hulgan T; Haas DW; Unutmaz D
PLoS Pathog; 2007 Apr; 3(4):e58. PubMed ID: 17465678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
